Synthomer Investors - SYNT

Synthomer Investors - SYNT

[ADVERT]
Best deals to access real time data!
Level 2 Basic
Monthly Subscription
for only
£62.08
Silver
Monthly Subscription
for only
£17.37
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type
Synthomer Plc SYNT London Ordinary Share
  Price Change Price Change % Stock Price Last Trade
3.80 0.82% 469.60 12:49:21
Open Price Low Price High Price Close Price Previous Close
477.40 465.00 477.40 465.80
more quote information »
Industry Sector
CHEMICALS

Top Investor Posts

DateSubject
22/6/2021
10:31
scooper72: In what sense do you see it as off the radar? I guess the price to earning ratio is relatively low, but of course that could simply mean that on balance investors have decided the risks and rewards in the future mean that the company doesn't deserve a higher rating. I see from Stockopedia that the Norwegian state wealth fund own a decent chunk of the company. For me that is always a good sign for long term quality holdings.
01/4/2021
00:43
philanderer: 31 March 2021 -- Moody's Investors Service ("Moody's") today affirmed Synthomer plc's (Synthomer) Ba2 corporate family rating (CFR), its Ba2-PD probability of default rating and the Ba2 rating of its E520 million backed senior unsecured notes due 2025. Concurrently, Moody's changed the outlook to stable from negative. "The stabilization of the outlook reflects Synthomer's strong performance in H2 2020, the successful delivery of synergies from the integration of OMNOVA Solutions Inc. (OMNOVA) and our expectation of further improving profitability in 2021," said Sven Reinke, a Senior Vice President and Lead Analyst for Synthomer. Yahoo Finance
17/11/2020
10:33
philanderer: 18th November 2020 14:30 to 16:30 GMT Synthomer plc – update post the Omnova acquisition (virtual event) (Invitation only - Please RSVP ir@synthomer.com if you would like to participate) HTTPS://www.synthomer.com/investor-relations/synthomer-plc/investor-home/?region=EUROPE
25/6/2020
15:12
lyndon b: What am I missing here. About 25% of synthomers sales is making latex for nitrile gloves (think blue medical gloves that everyone, even the public, are now wearing). Sales in this sector will be close to an all time high, yet investor support is a bit lackluster. The other part of their business will not be a car crash - resins for paints, as surely DIY is doing okay?
16/6/2020
23:56
philanderer: (Alliance News) - Moody's Investors Service on Tuesday assigned a Ba2 rating to Synthomer PLC's new EUR520 million senior unsecured notes, and the agency retained its negative outlook. The chemicals firm on Tuesday said it is planning to offer EUR520 million of unsecured senior notes due 2025 in order to refinance its bridge facility. "The affirmation of the Ba2 rating takes into account Synthomer's continued commitment to a conservative financial policy with the stated target of lowering the reported net leverage to 2x or less and also the company's good historic track record of integrating acquired businesses," Moody's explained. The notes are to be unconditionally guaranteed by certain of Sythomer's subsidiaries and the EUR520 million will be used to refinance the aqueous polymers supplier's existing EUR520 million bridge facility.
15/9/2019
09:21
robow: GREAT IDEAS 10 | SHARES | 12 September 2019 Chemicals firm Synthomer (SYNT) looks very tempting at the current price following a big sell-off over the past year. The firm’s share price dropped from around 530p a year ago to 280p last month and saw the stock trade on nearly its lowest rating in a decade, while its level of debt compared to how much it’s earning is expected to double. But with the business on the cusp of global expansion as it aims to keep up with soaring demand for its products, investors with a long-term view may want to take advantage of the firm’s cheap valuation. The chemicals sector has historically been a good place to invest with significant share price gains over the past decade and occasionally generous dividends. But chemicals companies have been caught up by concerns over a global economic slowdown in the past year, and some in the market think this may feed into weaker demand for chemicals products. Synthomer has tried to expand significantly to keep up with demand for its speciality products, sought after due to many factors such as urbanisation, ageing demographics and stricter legislation. The firm supplies aqueous polymers to companies, which The company should benefit from capacity expansion and a deal to boost its position in the US and Europe The outlook is looking brighter for Synthomer Synthomer is also forecast by analysts at Canaccord and Numis to have a much stronger second half of this year as market conditions are set to improve. That combined with its completed upgrades to facilities in Germany and Malaysia means the firm will have greater capacity to meet demand for its products. Its net debt-to-earnings ratio is expected to increase next year to between 2.2 and 3-times as the Omnova deal is completed. But Synthomer has a clear plan to get this down below 2-times by the end of 2021. Its management team has a disciplined approach to M&A, with a ‘conservative capital’ policy meaning it’s unlikely to ever be reckless in the pursuit of growth. help create new products and boost the performance of existing ones, such as footwear insoles, condoms, packaging tapes, carpets and waterproofing products. While strong on the consumer side, investors had questioned Synthomer’s growth prospects given its lack of real penetration into the industrial market. But the proposed deal to acquire Omnova Solutions, an American speciality chemicals business operating in sectors like construction and oil and gas, could make the market reappraise Synthomer. As well as the US, Omnova has manufacturing and technical facilities in Europe, Thailand and China. Analysts at UBS believe the acquisition will help Synthomer sell more products in the US, and help it expand its facilities in Europe. SYNT is also forecast by analysts at Canaccord and Numis to have a much stronger second half of this year as market conditions are set to improve. That combined with its completed upgrades to facilities in Germany and Malaysia means the firm will have greater capacity to meet demand for its products. Its net debt-to-earnings ratio is expected to increase next year to between 2.2 and 3-times as the Omnova deal is completed. But Synthomer has a clear plan to get this down below 2-times by the end of 2021. Its management team has a disciplined approach to M&A, with a ‘conservative capital’ policy meaning it’s unlikely to ever be reckless in the pursuit of growth. help create new products
09/7/2019
00:07
philanderer: Moody's Affirms Synthomer's Ba2 Rating But Cuts Outlook To Negative (Alliance News) (Alliance News) - Moody's Investors Service on Monday affirmed the Ba2 corporate family rating of Synthomer PLC, but changed its outlook to negative from stable. "Synthomer's announced acquisition of OMNOVA Solutions Inc is a good strategic fit and improves the company's scale and geographic diversification. However, the acquisition will result in Synthomer's leverage exceeding our guidance for the Ba2 rating and we expect that the company's leverage will remain elevated until 2021," said Sven Reinke, a senior vice president & lead analyst for Synthomer. The affirmation of the Ba2 rating takes into account Synthomer's continued commitment to lowering net leverage and the company's strong historic track record of integrating acquired HTTP://www.morningstar.co.uk/uk/news/AN_1562604109531092100/moodys-affirms-synthomers-ba2-rating-but-cuts-outlook-to-negative.aspx
03/7/2019
12:18
philanderer: This morning's analyst and investor presentation looks to have gone well :-)
21/3/2016
20:23
james dean: Acquisition Released : 21/03/2016 RNS Number : 6687S Synthomer PLC 21 March 2016 21 March 2016 Synthomer Plc Acquisition of HEXION Performance Adhesives & Coatings Synthomer plc (LSE:SYNT) ('Synthomer' or the 'Group'), a leading speciality chemicals company, today announces the acquisition of HEXION Performance Adhesives & Coatings ('HEXION PAC'), a business of HEXION Inc., a global chemical company based in Columbus, Ohio in the USA. The total consideration is $226 million (£156 million*) which is being funded from both existing cash resources and utilisation of additional credit facilities. The acquisition is expected to complete during the summer 2016 following receipt of regulatory approvals and satisfaction of other closing conditions. Hexion PAC develops, manufactures and markets a wide array of dispersions, additives, powder coatings and speciality monomers, supplying a global customer base across a broad range of end-use including coatings, adhesives and for building and construction applications. The business employs approximately 750 employees and operates 7 sites across Europe, the USA and Asia. In the year to 31 December 2015, HEXION PAC, generated sales of $370 million and EBITDA of $30 million. At 31 December 2015, HEXION PAC had gross assets of $149 million. It is expected that the acquisition will be earnings enhancing for Synthomer in the first full year. The existing leadership team of Hexion PAC will transfer with the business to Synthomer. The acquisition of HEXION PAC significantly strengthens Synthomer's position in the performance adhesives and coatings market, offering access to new product technologies, customers and markets. HEXION PAC is also highly complementary to Synthomer's existing business both geographically and in the markets in which it operates. Following completion, the Group will have a stronger platform from which to continue its growth aspirations in the Speciality Coatings market. Synthomer expects to achieve approximately $12m of annualised synergies by end 2018 through the integration of HEXION PAC's businesses into the Group. The estimated costs to achieve the synergies are $9m of restructuring costs and $12m of capital costs. The purchase price represents a pre-synergy multiple of 7.5x and a post-synergy multiple of 5.4x and the Group's pro-forma leverage will increase to approximately 1.5x based on the Group's 2015 year-end numbers. Calum MacLean, Chief Executive Officer of Synthomer, said: "The acquisition of HEXION PAC represents a further step forward in our strategy to continue to grow and develop the business. This acquisition strengthens our platform for continued growth in the global dispersions and additives market, and in particular expands our presence in the US and Asia. HEXION PAC has a good performance track record and shares our commitment to innovation and emphasis on strong customer relationships. We look forward to welcoming our new colleagues and integrating the business with Synthomer through the remainder of this year." *Foreign exchange rate for Sterling/US Dollar used is $1.45, being the rate as at 19 March 2016. - ENDS - Enquiries: Calum MacLean, Chief Executive Officer Tel: + 44 (0) 1279 436 211 Stephen Bennett, Chief Financial Officer Tel: + 44 (0) 1279 775 250 Charles Armitstead, Teneo Strategy Tel: + 44 (0) 207 240 2484 Conference call: The Company will hold a conference call for investors and analysts at 0900 BST today: Dial-in number: +44 (0) 207 1928 000 Conference ID: 75382782 This information is provided by RNS The company news service from the London Stock Exchange
16/1/2015
19:32
jeffcranbounre: Synthomer is featured on today's ADVFN podcast. To listen to the podcast click here> http://bit.ly/ADVFN0109 In today's podcast: - Technical Analyst and PR at Materinvestor.co.uk Zak Mir chatting and charting Quindell and it’s good news if you’re Quindell investor, Nanoco, Afren, Blur and should you invest in BP or Royal Dutch Shell? Zak on Twitter is @ZaksTradingCafe - And the micro and macro news including: Quindell #QPP Afren #AFR Royal Bank of Scotland #RBS Blur #BLUR Nanoco #NANO BP #BP. Royal Dutch Shell #RDSB Moneysupermarket.com #MONY GlaxoSmithKline #GSK Synthomer #SYNT JD Sports #JD. HSBC #HSBA Google #GOOG Standard Chartered #STAN Vedanta Resources #VED MyCelx Technologies #MYXR IG Group #IGG Shire #SHP AstraZeneca #AZN Smith (DS) #SMIN Dignity #DTY Tristel #TSTL Lancashire #LRE Wolseley #WOS Robert Walters #RWA Every Tuesday is Ten Bagger Tuesday on the podcast. If you know of a stock, whose share price has the potential to increase ten fold, just click the link below. Ten Bagger Tuesday (All it involves is filling out a form that will take you around 5 minutes and you don't personally appear on the podcast). Once a week, on a Friday, I feature a tip from a listener to this podcast, if you'd like to suggest a stock click the link below: Suggest a stock (Again all it involves is filling out a form that will take you around 5 minutes and you don't personally appear on the podcast). You can subscribe to this podcast in iTunes by clicking HERE To follow me on Twitter click HERE As a listener to the ADVFN podcast you can take advantage of some exclusive first year discounts on popular subscriptions: Bronze - £50 (normally £73.82/year) Silver - £145 (normally £173.71/year) Level 2 - £350 (normally £472.94/year) Call 0207 0700 961 and ask for the ADVFN Podcast discount to take advantage of these reduced rates or just CLICK HERE for more information. Please DO NOT buy any stock recommended in this podcast basely solely on what you hear. The opinions in this podcasts are just that, opinions. Please do you own research before investing. Justin    
ADVFN Advertorial
Your Recent History
LSE
SYNT
Synthomer
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211022 12:09:48